Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1978 Mar 18;118(6):635–638.

Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy

G Pylypchuk, DG Oreopoulos, DR Wilson, JE Harrison, KG McNeill, HE Meema, R Ogilvie, WC Sturtridge, TM Murray
PMCID: PMC1818056  PMID: 418865

Abstract

Long-term anticonvulsant drug therapy may lead to abnormalities of calcium metabolism resulting in osteomalacia. The prevalence and severity of altered calcium metabolism was studied in an adult outpatient population of persons with epilepsy receiving anticonvulsant therapy for a minimum of 2 years. Assessment of calcium metabolism was based on serum concentrations of calcium, phosphorus, alkaline phosphatase and 25-hydroxycholecalciferol and of plasma parathyroid hormone, intestinal absorption of isotopic calcium and skeletal bone mineral mass as determined by in vivo neutron activation or x-ray photodensitometry.

Thirty-nine patients who had been receiving anticonvulsant therapy for an average of 20 years were studied; none had clinical evidence of metabolic bone disease. Decreased serum calcium concentration was noted in 10%, decreased serum phosphorus concentration in 10% and elevated serum alkaline phosphatase concentration in 44%. The mean serum 25-hydroxycholecalciferol concentration was significantly lower (P < 0.001) than in a control group (11.6 v. 19.6 mg/mL). None of 18 patients studied had an increased plasma concentration of parathyroid hormone, and only 1 of 17 patients had decreased intestinal absorption of isotopic calcium. Bone mineral mass was decreased in 44% of 32 patients studied.

It was concluded that long-term treatment with anticonvulsant drugs leads to mild abnormalities of calcium metabolism and decreased bone mineral mass in a substantial percentage of adult outpatients with epilepsy. These abnormalities probably predispose the patients to the development of clinically significant metabolic bone disease.

Full text

PDF
635

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borgstedt A. D., Bryson M. F., Young L. W., Forbes G. B. Long-term administration of antiepileptic drugs and the development of rickets. J Pediatr. 1972 Jul;81(1):9–15. doi: 10.1016/s0022-3476(72)80366-4. [DOI] [PubMed] [Google Scholar]
  2. Bouillon R., Reynaert J., Claes J. H., Lissens W., De Moor P. The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab. 1975 Dec;41(06):1130–1135. doi: 10.1210/jcem-41-6-1130. [DOI] [PubMed] [Google Scholar]
  3. Christiansen C., Rodbro P., Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J. 1973 Dec 22;4(5894):695–701. doi: 10.1136/bmj.4.5894.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DeLuca H. F. The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone. N Engl J Med. 1973 Aug 16;289(7):359–365. doi: 10.1056/NEJM197308162890710. [DOI] [PubMed] [Google Scholar]
  5. Genuth S. M., Klein L., Rabinovich S., King K. C. Osteomalacia accompanying chronic anticonvulsant therapy. J Clin Endocrinol Metab. 1972 Sep;35(3):378–386. doi: 10.1210/jcem-35-3-378. [DOI] [PubMed] [Google Scholar]
  6. Haddad J. G., Chyu K. J. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971 Dec;33(6):992–995. doi: 10.1210/jcem-33-6-992. [DOI] [PubMed] [Google Scholar]
  7. Hahn T. J., Birge S. J., Scharp C. R., Avioli L. V. Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest. 1972 Apr;51(4):741–748. doi: 10.1172/JCI106868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hahn T. J., Hendin B. A., Scharp C. R., Haddad J. G., Jr Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med. 1972 Nov 2;287(18):900–904. doi: 10.1056/NEJM197211022871803. [DOI] [PubMed] [Google Scholar]
  9. Harrison J. E., McNeill K. G., Meema H. E., Fenton S., Oreopoulos D. G., Sturtridge W. C. Partial-body calcium measurements by in vivo neutron activation analysis: comparisons with x-ray photodensitometry measurements of the radius. J Nucl Med. 1974 Nov;15(11):929–934. [PubMed] [Google Scholar]
  10. Harrison J. E., McNeill K. G., Wilson D. R., Oreopoulos D. G., Krondl A., Finlay J. M. An evaluation of isotopic calcium absorption tests. Clin Biochem. 1973 Dec;6(4):237–245. doi: 10.1016/s0009-9120(73)80032-3. [DOI] [PubMed] [Google Scholar]
  11. Hosking D. J., Williams A., Godwin-Austen R. B., Allison S. P. Osteomalacia presenting as chorea. Br Med J. 1975 Jul 19;3(5976):136–138. doi: 10.1136/bmj.3.5976.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hunter J., Maxwell J. D., Stewart D. A., Parsons V., Williams R. Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J. 1971 Oct 23;4(5781):202–204. doi: 10.1136/bmj.4.5781.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kruse R. Osteopathien bei antiepileptischer Langzeittherapie (Vorläufige Mitteilung) Monatsschr Kinderheilkd. 1968 Jun;116(6):378–381. [PubMed] [Google Scholar]
  14. Kuntzman R. Drugs and enzyme induction. Annu Rev Pharmacol. 1969;9:21–36. doi: 10.1146/annurev.pa.09.040169.000321. [DOI] [PubMed] [Google Scholar]
  15. Lifshitz F., Maclaren N. K. Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. J Pediatr. 1973 Oct;83(4):612–620. doi: 10.1016/s0022-3476(73)80223-9. [DOI] [PubMed] [Google Scholar]
  16. Mosekilde L., Melsen F. Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors. Acta Med Scand. 1976;199(5):349–355. doi: 10.1111/j.0954-6820.1976.tb06747.x. [DOI] [PubMed] [Google Scholar]
  17. Murray T. M., Peacock M., Powell D., Monchik J. M., Potts J. T., Jr Non-autonomy of hormone secretion in primary hyperparathyroidism. Clin Endocrinol (Oxf) 1972 Jul;1(3):235–246. doi: 10.1111/j.1365-2265.1972.tb00394.x. [DOI] [PubMed] [Google Scholar]
  18. Silver J., Neale G., Thompson G. R. Effect of phenobarbitone treatment on vitamin D metabolism in mammals. Clin Sci Mol Med. 1974 Apr;46(4):433–448. doi: 10.1042/cs0460433. [DOI] [PubMed] [Google Scholar]
  19. Sotaniemi E. A., Hakkarainen H. K., Puranen J. A., Lahti R. O. Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy. Ann Intern Med. 1972 Sep;77(3):389–394. doi: 10.7326/0003-4819-77-3-389. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES